person · Reporting owner
Somaratne Ransi Mudalinayake
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Absci CorpABSI · Entity 4685 | CMO, Head of R&D | March 03, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Absci Corp
Report date March 03, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.57 · Expires 2036-03-02 | Direct | 650,000 |
Reported balance
After 2026-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 650,000 · Balance 650,000 F1: The shares subject to the option vest over four years, with 25% of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in 36 approximately equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.93 · Expires 2036-08-02 | Direct | 383,000 |
Reported balance
After 2026-08-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-03 · Grant · Acquired 383,000 · Balance 383,000 F1: The shares subject to the option vest over four years, with 25% of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in 36 approximately equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option vest over four years, with 25% of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in 36 approximately equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 7, 2026 20:54 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 383,000 | $0.00 Strike: $7.93 | $0.00 |
DisclosureSEC source: 0001672688-26-000129 · wk-form4_1786136049.xml · derivative · entry 2 Somaratne Ransi Mudalinayake · CIK 0002118661 · CMO, Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,000 Underlying: Common Stock · 383,000 shares Expires 2036-08-02 F1 · derivative.exercise_date: The shares subject to the option vest over four years, with 25% of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in 36 approximately equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 03, 2026 Filed Aug 7, 2026 20:54 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 650,000 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001672688-26-000129 · wk-form4_1786136049.xml · derivative · entry 1 Somaratne Ransi Mudalinayake · CIK 0002118661 · CMO, Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2036-03-02 F1 · derivative.exercise_date: The shares subject to the option vest over four years, with 25% of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in 36 approximately equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.